HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ropivacaine infusion in diabetics subject with peripheral arterial disease. A prospective study.

AbstractBACKGROUND:
Peripheral arterial disease (PAD) predicts cardiovascular and cerebrovascular ischemic events. PAD treatment is aimed at reducing clinical symptoms, local tissue loss and at preventing complications.
AIMS:
To evaluated the effect of peridural analgesia on peripheral perfusion and pain control.
METHODS:
In 280 diabetic subjects with severe limb ischemia (65.7% males and 34.3% females, mean age 59.3±14.4 years) with a failure of medical treatment and contraindications to endovascular and/or surgical reperfusion, we performed a 30-day long peridural ropivacaine infusion, monitoring blood pressure, VAS and ABI periodically.
RESULTS:
During ropivacaine infusion VAS significantly decreased (from 4.06±0.343 to 1.96±0.413, p<0.001). Furthermore, in the 261 (93.2%) subjects achieving a VAS value ≤2 during infusion, the effect was maintained after infusion withdrawing. ABI significantly improved both during infusion (from 0.30±0.04 at baseline to 0.65±0.05 at T30, p<0.001) and after infusion withdrawing as compared with baseline values.
CONCLUSIONS:
30-day peridural analgesia with ropivacaine is a valuable therapeutic option in severe peripheral limb ischemia subjects with contraindication to surgery and with pharmacological therapy failure.
AuthorsM N D Di Minno, M Milone, A Russolillo, R Lupoli, A Di Minno, P Maietta, C Iacovazzo, G Salvatore, F Milone
JournalExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association (Exp Clin Endocrinol Diabetes) Vol. 121 Issue 2 Pg. 91-3 (Feb 2013) ISSN: 1439-3646 [Electronic] Germany
PMID23147211 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.
Chemical References
  • Amides
  • Anesthetics, Local
  • Ropivacaine
Topics
  • Adult
  • Aged
  • Amides (administration & dosage, adverse effects, therapeutic use)
  • Anesthesia, Epidural
  • Anesthetics, Local (administration & dosage, adverse effects, therapeutic use)
  • Combined Modality Therapy (adverse effects)
  • Diabetes Mellitus, Type 2 (complications)
  • Diabetic Angiopathies (drug therapy, physiopathology, therapy)
  • Drug Resistance
  • Female
  • Follow-Up Studies
  • Humans
  • Intermittent Claudication (etiology, prevention & control)
  • Ischemia (complications, drug therapy, physiopathology, therapy)
  • Leg (blood supply)
  • Male
  • Middle Aged
  • Pain Measurement
  • Peripheral Arterial Disease (complications, drug therapy, physiopathology, therapy)
  • Prospective Studies
  • Regional Blood Flow (drug effects)
  • Ropivacaine
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: